查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1864799

主动脉瘤市场按治疗方法、动脉瘤类型、最终用户、器械类型、适应症、患者年龄层和性别划分 - 全球预测 2025-2032 年

Aortic Aneurysm Market by Treatment Modality, Aneurysm Type, End User, Device Type, Indication, Patient Age Group, Gender - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，主动脉瘤市场规模将达到 95.3 亿美元，复合年增长率为 8.97%。

主要市场统计数据
基准年 2024 47.9亿美元
预计年份：2025年 52.2亿美元
预测年份：2032年 95.3亿美元
复合年增长率 (%) 8.97%

全面介绍影响主动脉瘤治疗和相关人员决策的临床、技术和治疗方案发展动态。

主动脉瘤的治疗融合了外科手术创新、人口结构变化和不断发展的医疗服务模式。近年来，临床实务稳步转向微创手术，成像技术和医疗设备也取得了长足进步，围手术全期风险降低的重要性日益凸显。这些趋势，加上人口老化和心血管合併症负担加重，在持续推动临床需求的同时，也促使人们更加关注治疗方法的安全性、长期疗效以及成本效益。

深入分析临床创新、不断变化的医疗环境和监管趋势如何重塑相关人员对主动脉瘤治疗的认知范式。

主动脉瘤的治疗格局正在经历变革，这主要得益于技术的成熟、治疗环境的改变以及相关人员对价值的重新定义。微创血管内修復术已从一种小众替代方案发展成为多种解剖结构中的标准治疗方法，这得益于影像学、导航系统以及模组化血管支架设计的进步，这些技术能够到达以往无法手术的部位。这些进步，加上围手术全期优化技术和加速復健通讯协定的改进，正在透过缩短住院时间和减少手术相关併发症来改变临床治疗格局。

深入分析2025年实施的关税调整对主动脉瘤治疗生态系中医疗设备采购、生产策略和购买决策的影响。

2025年的关税调整为参与主动脉瘤治疗的医疗设备製造商、医疗系统和经销商的供应链引入了一个新的变数。许多用于血管内和开放手术的器械和组件都来自全球各地，进口关税的变化可能导致血管支架、合成导管和辅助输送组件的到岸成本上升。这些成本压力波及整个采购流程，迫使医院供应链团队重新谈判合约、重新评估供应商多元化策略，并评估某些生产和灭菌流程在地化的可行性。

透过对治疗方法、解剖结构复杂性、临床环境和患者人口统计特征进行細項分析，指导制定切实可行的临床和商业策略。

细分市场分析揭示了影响治疗方案选择、器材需求和医疗机构采纳的不同临床管道和商业性因素。基于治疗方法，临床医师会考虑患者的解剖结构和生理耐受力，权衡血管内修復与开放性手术。血管内技术越来越多地采用具有先进输送平台的血管支架系统来扩大应用范围，而开放手术则继续依赖生物导管和合成血管移植物，其耐久性和特定的解剖结构要求决定了手术方式。

区域评估揭示了医疗保健基础设施、报销方式和临床实践的差异如何影响全球主要地区的主动脉瘤治疗

区域差异导致临床实践、基础设施和监管要求有显着差异，进而影响主动脉瘤治疗的实施和产品商业化。在美洲，微创手术备受重视，并拥有完善的公共和私人医疗保险体系。先进的影像网路和高容量的三级医疗中心支援新型血管内移植物和复杂开窗解决方案的快速应用，同时，门诊也越来越多地承担低风险的择期手术病例。

针对医疗设备製造商的行业特定概述：创新管道供应链敏捷性和证据生成，以塑造竞争优势

主动脉瘤领域的企业策略以持续创新、临床证据的累积和业务规模的扩大为核心。领先的器械开发商正优先投资于新一代血管支架结构、低轮廓输送系统和材料科学，以改善长期疗效并扩大解剖覆盖范围。器械创新者与契约製造或影像技术公司之间的策略合作日益普遍，从而能够开发出植入性能与先进导航和术中成像技术相结合的解决方案。

为协调产品开发、供应链韧性和以金额为准化，以加速产品推广和临床应用，提出切实可行的策略建议。

产业领导者应采取多管齐下的策略，使产品创新与医疗服务趋势、监管预期和采购实践相契合。首先，优先发展模组化和解剖结构适应性强的器械平台，以降低手术复杂性，扩大微创治疗的适用人群，从而促进其在各种医疗机构中的广泛应用。其次，产生可靠的真实世界数据（RWE），并投资于註册登记，以提高支付方的接受度，检验长期安全性，并推动基于临床实践实际情况的产品迭代改进。

本文清晰地描述了用于获取主动脉瘤治疗临床、商业和供应链洞察的定性和定量相结合的研究方法。

本执行摘要的调查方法融合了定性和定量方法，以确保得出严谨且以证据为基础的研究结果。关键资讯来源包括对血管外科医生、介入医生、医院采购人员和医疗设备监管专家的访谈，以了解当前的临床实践、器械偏好和实施障碍。除了这些临床层面的观点外，还与供应链和商业负责人进行了讨论，以了解生产方面的考虑、分销动态以及近期贸易政策的影响。

简洁结论摘要了临床创新、供应链动态和策略要务之间的相互作用，这些因素将决定主动脉瘤治疗的未来成功。

主动脉瘤治疗正处于转折点，技术创新、人口压力和不断变化的医疗模式交汇融合，为临床医生、製造商和医疗系统带来了机会和挑战。微创血管内治疗策略的兴起正在拓展治疗适应症并改变资源分配，器械开发商也正积极推出创新产品，以应对解剖学上的挑战并确保器械的长期耐用性。同时，包括贸易趋势和支付方审查在内的商业和政策发展，也影响筹资策略和市场推广方式。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 整合影像导引功能的先进血管内主动脉修復装置的普及
  • 人工智慧演算法在动脉瘤风险分层和监测的应用日益广泛
  • 对结合开放性手术和血管内治疗的微创混合手术的需求日益增长
  • 增加对聚合物涂层技术的投资，以提高血管支架耐久性和生物相容性
  • 扩大远端医疗和远端患者监护在主动脉瘤术后监测的应用
  • 用于预测主动脉瘤生长的新型循环生物标记和液态生物检体检测方法
  • 重点关注动脉瘤风险管理中的个人化基因检测和精准医疗方法。
  • 监管和报销政策的转变加速了新一代血管支架核准和应用。
  • 人口老化导致主动脉瘤发生率上升，推动了对预防性筛检计画的需求。

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 主动脉瘤市场：依治疗方法

  • 血管内修復
    • 血管支架
  • 开放式手术修復
    • 生物通道
    • 合成血管移植物

9. 主动脉瘤市场（依动脉瘤类型划分）

  • 腹部主动脉血管瘤
    • 肾动脉下方
    • 肾旁
    • 肾上腺上
  • 胸主动脉瘤
    • 上升部分
    • 下降部分
    • 腹部主动脉血管瘤

第十章 主动脉瘤市场（依最终用户划分）

  • 门诊手术中心
    • 心臟病中心
    • 独立手术中心
  • 医院
    • 综合医院
    • 血管专科中心
    • 三级医院

第十一章 主动脉瘤市场（依器械类型划分）

  • 血管支架
  • 人工血管移植物

第十二章 主动脉瘤市场（依适应症划分）

  • 选择性修復
  • 破裂修復

第十三章 依病患年龄层分類的主动脉瘤市场

  • 65岁或以上
  • 65岁以下

第十四章 主动脉瘤市场：性别

  • 女士
  • 男性

第十五章 各地区主动脉瘤市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 主动脉瘤市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国主动脉瘤市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtronic plc
    • WL Gore & Associates, Inc.
    • Cook Medical LLC
    • Endologix, Inc.
    • Terumo Corporation
    • Lombard Medical Inc.
    • Jotec GmbH
    • Bolton Medical Limited
    • Artivion, Inc.
    • MicroPort Scientific Corporation
Product Code: MRR-D1342F184FD2

The Aortic Aneurysm Market is projected to grow by USD 9.53 billion at a CAGR of 8.97% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.79 billion
Estimated Year [2025] USD 5.22 billion
Forecast Year [2032] USD 9.53 billion
CAGR (%) 8.97%

An overarching introduction that frames the evolving clinical, technological, and delivery dynamics shaping aortic aneurysm treatment and stakeholder decision-making

Aortic aneurysm management sits at the intersection of surgical innovation, demographic shifts, and evolving healthcare delivery models. Recent years have seen the steady migration of clinical preference toward less invasive therapies, concurrent advances in imaging and device technology, and a heightened emphasis on perioperative risk mitigation. These dynamics converge against a backdrop of an ageing population with rising cardiovascular comorbidity burden, creating sustained clinical demand while simultaneously intensifying the focus on safety, long-term durability, and cost-effective pathways for intervention.

Clinicians and health system leaders are now navigating a more complex therapeutic landscape in which endovascular options must be balanced against open repair approaches based on anatomical suitability, patient frailty, and access-to-care considerations. Device designers are responding with increasingly sophisticated stent graft architectures, refined delivery systems, and adjunctive tools to address challenging anatomies such as short-necked infrarenal aneurysms and complex thoracoabdominal lesions. At the same time, payors and hospital administrators are scrutinizing procedural site selection and resource utilization, prompting closer evaluation of ambulatory surgery centers and streamlined care protocols.

This executive summary synthesizes current clinical trends, regulatory and commercial shifts, and provider-level strategic implications to support clinicians, manufacturers, and investors in making informed decisions. The analysis emphasizes actionable insights into modality choice, device differentiation, end-user adoption patterns, and regional variations that are shaping the path forward for aortic aneurysm care.

An in-depth analysis of how clinical innovation, care setting transitions, and regulatory emphasis are reshaping aortic aneurysm treatment paradigms across stakeholders

The landscape of aortic aneurysm care is undergoing transformative shifts driven by technological maturation, changing care settings, and the reframing of value across stakeholders. Minimally invasive endovascular repair has progressed from a niche alternative to a default option for many anatomies, supported by improved imaging fidelity, navigation systems, and modular stent graft designs that address previously inoperable segments. These advances are complemented by perioperative optimization techniques and enhanced recovery protocols that reduce length of stay and procedural morbidity, thereby altering the calculus of clinical decision-making.

Concurrently, device innovation is moving toward personalized solutions, including fenestrated and branched endografts, low-profile delivery systems, and materials engineered for long-term durability and reduced thrombogenicity. These innovations expand candidacy for endovascular approaches, particularly among older or comorbid patients who would face higher risks with open surgical repair. The shift is not purely technological; it reflects an ecosystem change where multidisciplinary teams, including vascular surgery, interventional radiology, and cardiac surgery, increasingly collaborate to tailor therapy to patient-specific anatomy and risk profiles.

Health systems are also redefining care pathways, directing lower-risk elective procedures to ambulatory settings and employing telemedicine and remote monitoring for follow-up surveillance. This decentralization of care pressures device manufacturers to standardize training, simplify deployment, and ensure consistent outcomes across disparate settings. Lastly, regulatory emphasis on post-market surveillance and real-world evidence is prompting companies to invest in registries and longitudinal studies, which in turn inform clinical guidelines and payer coverage policies. Together, these shifts create both opportunity and competitive pressure for stakeholders to adapt strategy, investment, and product development roadmaps.

A detailed exploration of how the 2025 United States tariff changes have influenced device sourcing, manufacturing strategies, and procurement decisions across the aortic aneurysm ecosystem

Tariff adjustments implemented in the United States in 2025 introduced a new variable into the supply chain calculus for medical device manufacturers, health systems, and distributors involved in aortic aneurysm care. Many devices and components used in endovascular and open surgical repairs are sourced globally, and changes in import duties can result in increased landed costs for stent grafts, synthetic conduits, and ancillary delivery components. These cost pressures ripple through procurement processes, prompting hospital supply chain teams to renegotiate contracts, reassess supplier diversification strategies, and evaluate the feasibility of localizing certain manufacturing or sterilization processes.

The cumulative impact of the tariff measures has prompted manufacturers to reassess their global sourcing footprints, with some prioritizing regional production hubs to mitigate exposure to trade fluctuations. For devices that rely on specialized raw materials or implants produced by a limited set of suppliers, tariffs have amplified the need for transparent cost structures and contingency planning. Health systems facing constrained operating budgets may respond by enhancing value-based contracting, extending device reuse policies within regulatory allowances, or prioritizing procedural modalities that demonstrate stronger cost-effectiveness in their local contexts.

Regulatory and reimbursement bodies have also taken notice, and the interplay between import duties and pricing has the potential to alter negotiations around bundled payments and procedural reimbursement. For international suppliers, tariff-induced pricing changes may slow market entry or shift commercialization timelines, particularly for high-complexity devices that require substantial clinical evidence prior to adoption. Ultimately, the 2025 tariff environment underscores the importance of supply-chain resilience, flexible manufacturing strategies, and closer collaboration between manufacturers and providers to preserve access to life-saving aortic aneurysm interventions while managing economic impacts.

Segment-driven insights that connect treatment modalities, anatomical complexity, care settings, and patient demographics to actionable clinical and commercial strategies

Segmentation analysis reveals distinct clinical pathways and commercial considerations that influence treatment selection, device demand, and provider adoption. Based on treatment modality, clinicians weigh endovascular repair against open surgical repair by considering patient anatomy and physiological resilience; endovascular techniques increasingly leverage stent graft systems with advanced delivery platforms to expand applicability, while open surgical repair continues to rely on both biological conduits and synthetic vascular grafts where durability and specific anatomical requirements dictate approach.

When viewed through the lens of aneurysm type, abdominal aortic aneurysms and thoracic aortic aneurysms present different technical challenges and device requirements. Abdominal presentations are further stratified by infrarenal, juxtarenal, and suprarenal locations, each demanding unique fixation and sealing strategies, whereas thoracic presentations span ascending, descending, and thoracoabdominal segments that often require branched or fenestrated designs to preserve branch vessel integrity. These anatomical distinctions drive product development priorities, imaging protocols, and operator training needs.

End-user segmentation highlights divergent adoption curves and procedural settings. Ambulatory surgery centers, including cardiology-centered facilities and standalone surgery centers, are increasingly attractive for lower-risk, elective interventions that benefit from streamlined throughput and lower overhead. Conversely, hospitals, whether general, specialized vascular centers, or tertiary care institutions, maintain primacy for high-complexity cases and ruptured presentations that require multidisciplinary resources and critical care capabilities.

Device type segmentation isolates stent graft systems and synthetic vascular grafts as core product categories, each with unique regulatory pathways, sterilization requirements, and surgeon preferences. Indication-based segmentation differentiates elective repairs, where optimization of recovery and cost containment are priorities, from rupture repairs, which demand immediate access to robust devices and emergent care pathways. Patient demographics further nuance demand patterns, with an older cohort driving higher procedural volume and anatomical complexity; gender differences shape risk stratification and anatomical fit considerations, necessitating inclusive design and evidence generation across populations.

A regional assessment highlighting how divergent healthcare infrastructures, reimbursement approaches, and clinical practices shape aortic aneurysm care across major global geographies

Regional dynamics produce meaningful variation in clinical practice, infrastructure readiness, and regulatory expectations that affect how aortic aneurysm care is delivered and how products are commercialized. In the Americas, there is a strong emphasis on minimally invasive approaches coupled with robust private and public payer systems; advanced imaging networks and high-volume tertiary centers support rapid adoption of novel endografts and complex fenestrated solutions, while ambulatory settings are progressively absorbing lower-risk elective cases.

Europe, Middle East & Africa present a heterogeneous landscape where western European markets emphasize guideline-driven adoption and centralized specialized vascular centers, and emerging markets across the Middle East and Africa grapple with infrastructure constraints and variable access to advanced devices. Regulatory alignment with regional authorities and investments in training and centers of excellence are critical to expanding reach across these diverse healthcare systems.

Asia-Pacific demonstrates accelerated uptake in innovation in several urbanized markets that combine high procedure volumes with expanding ambulatory infrastructures. Local manufacturing capacities and partnerships with global manufacturers are shaping access and price dynamics, while demographic trends and public health initiatives are increasing screening and early detection efforts. Across regions, differences in reimbursement structures, clinical guideline adoption, and workforce availability create distinct strategic imperatives for manufacturers and providers seeking sustainable growth and clinical impact.

An industry-focused overview of how innovation pipelines, supply chain agility, and evidence generation are shaping competitive differentiation among device manufacturers

Corporate strategy in the aortic aneurysm domain centers on sustained innovation, clinical evidence generation, and operational scale. Leading device developers prioritize investments in next-generation stent graft architectures, low-profile delivery systems, and materials science to improve long-term outcomes and broaden anatomical applicability. Strategic alliances between device innovators and contract manufacturers or imaging technology firms are increasingly common, enabling integrated solutions that combine implant performance with advanced navigation and intraoperative imaging.

Investment in post-market surveillance and real-world data initiatives has become a differentiator, supporting regulatory submissions, payer negotiations, and clinician confidence. Firms that can demonstrate comprehensive training programs, robust customer support, and streamlined logistics achieve higher penetration across ambulatory and hospital settings. Meanwhile, smaller and emerging medtech companies focus on niche innovations-such as branched configurations for complex thoracoabdominal repairs or biologically optimized graft materials-positioning themselves for acquisition or strategic partnerships with larger players.

Supply-chain agility and regional manufacturing presence influence competitive positioning, particularly in areas affected by trade policy shifts. Companies that proactively localize production or diversify supplier networks reduce exposure to tariff volatility and distribution bottlenecks. Additionally, those that invest in digital tools for follow-up surveillance, patient-reported outcomes, and remote monitoring create differentiated value propositions for health systems prioritizing longitudinal care and cost containment.

Actionable strategic recommendations that align product development, supply chain resilience, and value-based commercialization to accelerate adoption and clinical impact

Industry leaders should adopt a multi-pronged strategy that aligns product innovation with care delivery trends, regulatory expectations, and procurement realities. First, prioritize modular and anatomically adaptable device platforms that reduce procedure complexity and expand the pool of patients eligible for less invasive treatment, thereby enabling broader adoption across diverse care settings. Second, invest in robust real-world evidence generation and registries to accelerate payer acceptance, validate long-term safety, and inform iterative product improvements that are grounded in clinical practice realities.

Third, strengthen supply-chain resilience by diversifying supplier bases, exploring regional production hubs, and developing contingency plans for component sourcing to mitigate the impact of trade policy shifts. Fourth, tailor commercial approaches to end-user segmentation by offering targeted training and support programs for ambulatory surgery centers, and by providing integrated clinical pathways for tertiary hospitals managing complex rupture cases. Fifth, collaborate with health systems to pilot bundled-care models and outcome-based contracts that align reimbursement with value delivered, thus improving access while demonstrating cost-effectiveness.

Finally, foster multidisciplinary clinician engagement and invest in education that promotes appropriate patient selection, surveillance protocols, and secondary prevention; this clinician-centric approach supports safer adoption of novel devices and strengthens long-term patient outcomes. These combined actions will position organizations to capture clinical and commercial opportunities while managing operational risks.

A transparent explanation of the blended qualitative and quantitative research approach used to derive clinical, commercial, and supply chain insights for aortic aneurysm care

The research methodology underpinning this executive summary integrates qualitative and quantitative approaches to ensure rigorous, evidence-based insights. Primary inputs include expert interviews with vascular surgeons, interventionalists, hospital procurement leaders, and device regulatory specialists to capture current clinical practice, device preferences, and adoption barriers. These clinician-level perspectives are supplemented by discussions with supply-chain and commercial leaders to understand manufacturing considerations, distribution dynamics, and the implications of recent trade policies.

Secondary research involved a systematic review of peer-reviewed clinical literature, regulatory guidance documents, and professional society position statements to validate clinical trends and device-specific performance characteristics. Where appropriate, registry data and published post-market surveillance reports were analyzed to assess safety signals and durability considerations, and findings were triangulated across multiple sources to enhance robustness. The segmentation framework was applied to map product types, indications, end-user settings, and patient cohorts to ensure that insights reflect the diversity of clinical pathways and commercial channels.

Finally, analytic rigor was maintained through cross-validation of thematic findings with independent experts and iterative refinement of conclusions to reflect both clinical nuance and commercial realism. This blended methodology supports actionable recommendations while acknowledging areas where evidence remains emergent and where ongoing surveillance will be required.

A concise conclusion summarizing the interplay of clinical innovation, supply chain dynamics, and strategic imperatives that will determine future success in aortic aneurysm care

Aortic aneurysm care is at an inflection point where technological innovation, demographic pressures, and changing care models intersect to create both opportunity and complexity for clinicians, manufacturers, and health systems. The move toward minimally invasive endovascular strategies is broadening treatment candidacy and shifting resource allocation, while device developers respond with targeted innovations that address anatomical challenges and long-term durability. At the same time, commercial and policy developments, including trade dynamics and payer scrutiny, are influencing procurement strategies and go-to-market approaches.

Stakeholders that align product development with clinical evidence, invest in training and post-market surveillance, and build resilient supply chains will be best positioned to deliver patient-centered outcomes while achieving sustainable commercial performance. Embracing collaborative models with health systems and payers that emphasize value and outcomes will further enable access to advanced therapies and support the long-term viability of innovative solutions. As the landscape continues to evolve, continued monitoring of clinical data, regulatory developments, and regional care models will be essential to refine strategies and maintain alignment with emerging best practices.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Surge in advanced endovascular aortic repair devices with integrated imaging guidance
  • 5.2. Increasing adoption of artificial intelligence algorithms for aneurysm risk stratification and monitoring
  • 5.3. Rising demand for minimally invasive hybrid procedures combining open and endovascular techniques
  • 5.4. Growing investment in polymer coating technologies to enhance stent graft durability and biocompatibility
  • 5.5. Expansion of telemedicine and remote patient monitoring for post-operative aortic aneurysm surveillance
  • 5.6. Emergence of novel circulating biomarkers and liquid biopsy assays for aneurysm growth prediction
  • 5.7. Focus on personalized genetic testing and precision medicine approaches in aneurysm risk management
  • 5.8. Regulatory and reimbursement policy shifts accelerating approval and adoption of next-gen stent grafts
  • 5.9. Rising incidence of aortic aneurysms in aging populations driving demand for preventive screening programs

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Aortic Aneurysm Market, by Treatment Modality

  • 8.1. Endovascular Repair
    • 8.1.1. Stent Graft
  • 8.2. Open Surgical Repair
    • 8.2.1. Biological Conduit
    • 8.2.2. Synthetic Vascular Graft

9. Aortic Aneurysm Market, by Aneurysm Type

  • 9.1. Abdominal Aortic Aneurysm
    • 9.1.1. Infrarenal
    • 9.1.2. Juxtarenal
    • 9.1.3. Suprarenal
  • 9.2. Thoracic Aortic Aneurysm
    • 9.2.1. Ascending
    • 9.2.2. Descending
    • 9.2.3. Thoracoabdominal

10. Aortic Aneurysm Market, by End User

  • 10.1. Ambulatory Surgery Centers
    • 10.1.1. Cardiology Centers
    • 10.1.2. Standalone Surgery Centers
  • 10.2. Hospitals
    • 10.2.1. General Hospitals
    • 10.2.2. Specialized Vascular Centers
    • 10.2.3. Tertiary Care Hospitals

11. Aortic Aneurysm Market, by Device Type

  • 11.1. Stent Graft
  • 11.2. Synthetic Vascular Graft

12. Aortic Aneurysm Market, by Indication

  • 12.1. Elective Repair
  • 12.2. Rupture Repair

13. Aortic Aneurysm Market, by Patient Age Group

  • 13.1. 65 And Above
  • 13.2. Under 65

14. Aortic Aneurysm Market, by Gender

  • 14.1. Female
  • 14.2. Male

15. Aortic Aneurysm Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Aortic Aneurysm Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Aortic Aneurysm Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Medtronic plc
    • 18.3.2. W. L. Gore & Associates, Inc.
    • 18.3.3. Cook Medical LLC
    • 18.3.4. Endologix, Inc.
    • 18.3.5. Terumo Corporation
    • 18.3.6. Lombard Medical Inc.
    • 18.3.7. Jotec GmbH
    • 18.3.8. Bolton Medical Limited
    • 18.3.9. Artivion, Inc.
    • 18.3.10. MicroPort Scientific Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. AORTIC ANEURYSM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. AORTIC ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. AORTIC ANEURYSM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY BIOLOGICAL CONDUIT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INFRARENAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY JUXTARENAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SUPRARENAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ASCENDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DESCENDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACOABDOMINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STANDALONE SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SPECIALIZED VASCULAR CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY SYNTHETIC VASCULAR GRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ELECTIVE REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY RUPTURE REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY 65 AND ABOVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY UNDER 65, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY FEMALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY MALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE AORTIC ANEURYSM MARKET SIZE, BY TREATMENT MODALITY, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ANEURYSM TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE AORTIC ANEURYSM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE AORTIC ANEURYSM MARKET SIZE, BY END USER, 2025-2032 (USD MIL